Micronutrients and the Premenstrual Syndrome: The Case for Calcium

Journal of the American College of Nutrition

Volumn 19, Issue 2, 2000, Pages 220-227

  Thys Jacobs, Susan ^a  

^a Columbia University ^*  (United States)

Author keywords

Calcium; Magnesium; Parathyroid hormone; Premenstrual syndrome; Vitamin D

Indexed keywords

CALCIUM; ESTROGEN; MAGNESIUM; PARATHYROID HORMONE; STEROID HORMONE; TRACE ELEMENT; VITAMIN D;

AFFECTIVE NEUROSIS; ANXIETY; BEHAVIOR; CALCIUM HOMEOSTASIS; CALCIUM METABOLISM; CLINICAL TRIAL; DEPRESSION; DIET SUPPLEMENTATION; DYSPHORIA; EVIDENCE BASED MEDICINE; FEMALE; HUMAN; LUTEAL PHASE; MAGNESIUM METABOLISM; MENSTRUAL CYCLE; MOOD; NUTRIENT; PREMENSTRUAL SYNDROME; REVIEW; SECONDARY HYPERPARATHYROIDISM; VITAMIN D DEFICIENCY; VITAMIN D METABOLISM;

CALCITRIOL; CALCIUM; DEPRESSION; FEMALE; HOMEOSTASIS; HUMANS; MAGNESIUM; MENSTRUAL CYCLE; PREMENSTRUAL SYNDROME; VITAMINS;

EID: 0034125663     PISSN: 07315724     EISSN: 15411087     Source Type: Journal    
DOI: 10.1080/07315724.2000.10718920     Document Type: Article

References (55)

1. Frank RT: The hormonal causes of premenstrual tension. Arch Neurol Psychiatry 26: 1053-57, 1931.
2. Reid RL, Yen SSC: Premenstrual syndrome. Am J Obstet Gynecol 139: 85-104, 1981.
3. Bruce J, Russel G: Premenstrual tension. A study of weight changes and balances of water sodium and potassium. Lancet 2: 267-271, 1962.
4. Aedo AR, Langren BM, Cekan Z, Diczfalusy E: Studies on the pattern of circulating steroids in the normal menstrual cycle. Acta Endocrinol (Copenh) 82: 600-616, 1976.
5. Urban RJ, Veldhuis JD, Dufau ML: Estrogen regulates the GnRHstimulated secretion of biologically active LH. J Clin Endocrinol Metab 72: 660-668, 1991.
6. Rubinow DR, Hoban MC, Grover GN, Galloway DS, Roy-Byrne P, Andersen R, Merriam GR: Changes in plasma hormones across the menstrual cycle in patients with menstrually related mood disorder and in control subjects. Am J Obstet Gynecol 158: 5-11, 1988.
7. Facchinetti F, Genazzani AD, Martignoni E, Fioroni L, Sances G, Genazzani AR: Neuroendocrine correlates of premenstrual syndrome: changes in the pulsatile pattern of plasma LH. Psychoneuroendocrinology 15: 269-277, 1990.
8. Cerin A, Collins A, Landgren BM, Eneroth P: Hormonal andbiochemical profiles of premenstrual syndrome. Acta Obstet Gynecol Scand 72: 337-343, 1993.
9. Andersch B, Abrahamsson L, Wenderstem C, Ohman R, Hahn L: Hormone profiles in premenstrual tension: effects of bromocriptine and diuretics. Clin Endocrinol 11: 657-64, 1979.
10. Mortola JF, Girton L, Yen S: Depressive episodes in premenstrual syndrome. Am J Obstet Gynecol 161: 1682-7, 1989.
11. Andersch B: Bromocriptine and premenstrual symptoms: a survey of double blind trials. Obstet Gynecol Sur 38: 643-6, 1983.
12. Ferrin M, Jewelewicz R, Warren M: The premenstrual syndrome. In –The Menstrual Cycle.— Oxford University Press pp 198-204, 1993.
13. Mortola JF, Girton L, Fischer U: Successful treatment of severe premenstrual syndrome by combined use of gonadotropinreleasing hormone agonist and estrogen/progestin. J Clin Endocrinol Metab 71: 252A-252F, 1991.
14. Casson P, Hahn PM, Van Vugt DA, Reid RL: Lasting response to ovariectomy in severe intractable premenstrual syndrome. Am J Obstet Gynecol 162: 99-105, 1990.
15. Muse KN, Cetel NS, Futterman LA, Yen SSC: The premenstrual syndrome: effects of medical ovariectomy. N Engl J Med 311: 1345-1349, 1984.
16. Schmidt PJ, Nieman LK, Danaceau MA, Adams LF, Rubinow DR: Differential behavioral effects of gonadal steroids in women with and without premenstrual syndrome. N Engl J Med 338: 209-216, 1998.
17. Cressent M, Elie C, Taboulet J, Moukhtar S, Milhaud: Calcium regulating hormones during the estrous cycle of the rat. Proc Soc Exp Biol Med 172: 158-162, 1983.
18. Piffaretti JM: Etude des variations des taux plasmatiques du phosphore inorganique, du calcium et du magnesium au cours du rythme nycthemeral et menstruel chez la femme normale. Schweiz Rundsch Med Prax 61: 670-677, 1972.
19. Sato N, Henkin RI: Pituitary-gonadal regulation of copper and zinc metabolism in the female rat. Am J Physiol 225: 508-512, 1973.
20. Kenny A: Vitamin D metabolism: physiological regulation in egg-laying Japanese quail. Am J Physiol 230: 1609-1615, 1976.
21. Tanaka Y, Castillo L, Deluca HF: Control of renal vitamin D hydroxylases in birds by sex hormones. Proc Natl Acad Sci 73: 2701-2705, 1976.
22. Brommage R, Binacua C, Carrie AL: Ovulation-associated increase in intestinal calcium absorption during the rat estrous cycle is blunted by ovariectomy. Biol Reprod 49: 544-548, 1993.
23. Pitkin R, Reynolds WA, Williams GA, Hargis GK: Calcium regulating hormones during the menstrual cycle. J Clin Endocrinol Metab 47: 626-632, 1978.
24. Gray TK, McAdoo T, Hatley L, Lester GE, Thierry M: Fluctuation of serum concentration of 1,25 dihydroxyvitamin D during the menstrual cycle. Am J Obstet Gynecol 144: 880-884, 1982.
25. Tjellesen L, Christiansen C, Hummer L, Larsen NE: Unchanged biochemical indices of bone turnover despite fluctuations in 1,25 dihydroxyvitamin D during the menstrual cycle. Acta Endocrinologica 102: 476, 1983.
26. Das K, Chowdhury AR: Metallic ions during menstrual cycle in normally menstruating women. Indian J Med Sci 51: 52-4, 1997.
27. Muneyyirci-Delale O, Nacharaju V, Dalloul M, Altura B, Altura BT: Serum ionized magnesium and calcium in women after menopause: inverse relation of estrogen with ionized magnesium. Fertil Steril 71: 869-872, 1999.
28. London RS, Murphy L, Kitlowski KE, Reynolds MA: Efficacy of alpha-tocopherol in the treatment of the premenstrual syndrome. J Reprod Med 32: 400-404, 1987.
29. Wyatt KM, Dimmock PW, Jones PW, Shaugn O'Brien PM: Efficacy of vitamin B6 in the treatment of premenstrual syndrome: systematic review. BMJ 318: 1375-1381, 1999.
30. Collins A, Cerin A, Coleman G, Landgren BM: Essential fatty acids in the treatment of premenstrual syndrome. Obstet Gynecol 81: 93-98, 1993.
31. Khoo SK, Munro C, Battistutta D: Evening primrose oil and treatment of premenstrual syndrome. Med J Aust 153: 189-192, 1990.
32. Reeves BD, Garvin JE, McElin TW: Premenstrual tension: Symptoms and weight changes related to potassium therapy. Am J Obstet Gyn 109: 1036-1041, 1971.
33. Facchinetti F, Borella P, Sances G, Fioroni L, Nappi RE, Genazzani AR: Oral magnesium successfully relieves premenstrual mood changes. Obstet Gynecol 78: 177-181, 1991.
34. Walker AF, De Souza M, Vickers MF: Magnesium supplementation alleviates premenstrual symptoms of fluid retention. J Women's Health 7: 1157-1165, 1998.
35. Thys-Jacobs S, Ceccarelli S, Bierman A, Weisman H, Cohen MA, Alvir J: Calcium supplementation in premenstrual syndrome. J Gen Intern Med 4: 183-189, 1989.
36. Penland JG, Johnson PE: Dietary calcium and manganese effects on menstrual cycle symptoms. Am J Obstet Gynecol 168: 1417-1423, 1993.
37. Thys-Jacobs S, Starkey P, Bernstein D, Tian J: Calcium carbonate and the premenstrual syndrome: effects on premenstrual and menstrual symptoms. Am J Obstet Gynecol 179: 444-52, 1998.
38. Lee SJ, Kanis JA: An association between osteoporosis and premenstrual and postmenstrual symptoms. Bone and Mineral 24: 127-134, 1994.
39. Thys-Jacobs S, Silverton M, Alvir J, Paddison P, Rico M, Goldsmith S: Reduced bone mass in women with premenstrual syndrome. J Women's Health 4: 161-168, 1995.
40. Thys-Jacobs S, Alvir MAJ: Calcium regulating hormones across the menstrual cycle: evidence of a secondary hyperparathyroidism in women with PMS. J Clin Endocrinol Metab 80: 2227-2232, 1995.
41. Weston PG, Howard MQ: The determination of sodium, potassium, calcium and magnesium in the blood and spinal fluid of patients suffering from manic depressive insanity. Arch Neurol Psychiat 8: 179-183, 1922.
42. Carman JS, Crews E, Bancroft A, et al.: Calcium and calcium regulating hormones in the biphasic periodic psychoses. J Operational Psychiat 11: 5-17, 1980.
43. Jimerson DC, Post R, Carman JS, van Kammen DP, Wood JH, Goodwin FK: CSF calcium: clinical correlates in affective illness and schizophrenia. Biol Psychiat 14: 37-51, 1979.
44. Borer M, Bhanot V: Hyperparathyroidism: neuropsychiatric manifestations. Psychosomatics 26: 597-601, 1985.
45. Joborn C, Hetta J, Palmer M, Akerstrom G, Ljunghall S: Psychiatric symptomatology in patients with primary hyperparathyroidism. Upsala J Med 91: 77-87, 1986.
46. Joborn C, Hetta J, Johsnsson H, Rasstad J, Agren H, Akerstrom G, Ljunghall S: Psychiatric morbidity in primary hyperparathyroidism. World J Surg 12: 476-481, 1988.
47. Joborn C, Hetta J, Rastad J, Agren H, Akerstrom, Ljunghall S: Psychiatric symptoms and cerebrospinal fluid monoamine metabolites in primary hyperparathyroidism. Biol Psychiatry 23: 149-158, 1988.
48. Asberg M, Bertilsson L, Martensson B, Scalia-Tomba GP, Thoren P, Traskanman Bendz L: CSF monoamines metabolites in melancholia. Acta Psychiatr Scand 69: 201-205, 1984.
49. Traskman L, Asberg M, Bertilsson L, Sjostrand L: Monoamine metabolites in CSF and suicidal behavior. Arch Gen Psychiatry 38: 631-639, 1981.
50. Rapkin AJ: The role of serotonin in premenstrual syndrome. Clin Obstet Gynecol 35: 629-636, 1922.
51. Steiner M, Steinberg S, Stewart D, Carter D, Berger C, Reid R, Grover D, Streiner D: Fluoxetine in the treatment of premenstrual dysphoria. N Engl J Med 332: 1529-34, 1995.
52. Gallagher JC, Riggs BL, Deluca HF: Effect of estrogen on calcium absorption and serum vitamin D metabolites in postmenopausal osteoporosis. J Clin Endocrinol Metab 51: 1359-1364, 1980.
53. Young MN, Nordin BEC: Effect of natural and artificial menopause on plasma and urinary calcium and phosphorus. Lancet 2: 118, 1967.
54. Heaney RP: Estrogens and postmenopausal osteoporosis. Clin Obstet Gyecol 19: 791, 1976.
55. Stice SL, Ford SP, Rosazza JP, Van-Orden DE: Role of 4-hydroxylated estradiol in reducing Ca21 uptake of uterine arterial smooth muscle cells through potential sensitive channels. Biol Reprod 36: 361-368, 1987.